Women were less than half of the people tested for almost all of these common medicines.

High blood pressure

lisinopril

One of the most prescribed blood-pressure pills, and not one study we found looked at women's results separately.

  • 42.5%

    of the people in the studies were women

  • 47%

    of studies did not allow pregnant women

  • 0%

    looked at results for women separately

Was someone like me tested?

Choose the group that fits you.

Not one of these studies reported results separately for any of the groups below.

Not studied

Pregnant women

47% of studies would not let pregnant women join, and we found no study that tested this medicine in pregnancy.

What do we know?

What the FDA drug label says

Can seriously harm or kill an unborn baby, especially in the 2nd and 3rd trimesters. Stop taking it as soon as you know you are pregnant, and talk to your doctor.

Good to know

A dry, nagging cough is a common side effect and is reported more often by women.

What women report more

Compared with men taking the same medicine.

  • 2.9ร—Changes to the front of the eye
  • 2.4ร—Joint lining and bursa swelling
  • 2.1ร—Ear problems
  • 2.0ร—Broken bones

How many times more often women reported each problem than men taking the same medicine, based on reports to the FDA. This is a warning sign, not proof the medicine caused it.

Make it about you

Check it against your medicines

Check lisinopril against the medicines, pregnancy and birth control in your profile.

Join to check

Women's experiences

Join or sign in to share, like or save. You'll fill in a short health profile so your story has context and we can check your medicines.

No one has shared yet. Your story could help the next woman.

All the details

Every number behind this page.

Who was in the studies

18,559 people in 34 studies

7,894 womenmiddle line = equal numbers10,665 men

Race

  • White89.7%
  • Black / African American8.8%
  • Asian0.7%
  • American Indian / Alaska Native0.2%
  • More than one race0.2%

Studies didn't say how many of the women were Black, Asian or another race โ€” only totals for everyone.

Hispanic or Latina
9.3%
Age 65 or older
8.1%
Studies with men only
2
Studies with women only
0
Rules that kept women out

Share of studies with each rule.

  • 59%

    No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    See the exact rule
    โ€œuncontrollable or symptomatic arrhythmias unstable angina or angina treated with a beta-blocker sick sinus syndrome or second or third degree heart block (unless treated with a permanent, functioning pacemaker) bradycardia (sitting heart raโ€ฆโ€ NCT00347360
  • 47%

    No pregnant women

    Women who were pregnant could not join.

    See the exact rule
    โ€œFemales must be post-menopausal, or not pregnant and using an approved contraceptive regimenโ€ NCT01218100
  • 38%

    No diabetes

    Women with diabetes were turned away.

    See the exact rule
    โ€œSubject has DBP =90 mmHg (or for diabetic subjects, DBP =80 mmHg) on two antihypertensive medications.โ€ NCT00347360
  • 27%

    Had to use birth control

    Women who couldn't or didn't want to use birth control were turned away.

    See the exact rule
    โ€œFemales must be post-menopausal, or not pregnant and using an approved contraceptive regimenโ€ NCT01218100
  • 21%

    No breastfeeding moms

    Women who were breastfeeding could not join.

    See the exact rule
    โ€œPregnancy or lactation.โ€ NCT02336607
  • 21%

    Age limit under 65

    Older women were turned away, even though they often take this medicine.

    See the exact rule
    โ€œMaximum age: 64 Years.โ€ NCT01218100
What nobody checked

Share of studies that recorded each thing.

  • 0%
    Results shown separately for women
  • 0%
    Whether anyone was pregnant
  • 0%
    Whether women were past menopause
  • 15%
    Body weight (BMI)
  • 15%
    Hispanic / Latina or not
  • 53%
    Race
All 34 studies

Study titles and rules are shown in their original English.

StudyPhasepeople% women
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
NCT00000620
310,25138.6%
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension
NCT01218100
466142.1%
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
NCT00347360
365435.5%
HALT Progression of Polycystic Kidney Disease Study A
NCT00283686
355849.3%
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
NCT00673790
453743.9%
Reducing Total Cardiovascular Risk in an Urban Community
NCT00241904
452571.2%
Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients
NCT00734630
449139.9%
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
NCT02603809
249039.2%
HALT Progression of Polycystic Kidney Disease Study B
NCT01885559
348651.6%
The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.
NCT02336607
โ€”48144.7%
Lisinopril or Coreg CRยฎ in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
NCT01009918
2468100%
Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
NCT00624065
343244%
The CLEVER Study - Coreg And Left Ventricular Mass Regression
NCT00108082
328744.6%
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
NCT01669434
427551.6%
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846
425228.6%
CAndesartan vs LIsinopril Effects on the BRain
NCT01984164
217657.4%
Black Education and Treatment of Hypertension (BEAT HTN)
NCT00661895
49972.7%
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
NCT00553969
1/29128.6%
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
NCT00605072
25358.5%
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
NCT01324388
15135.3%
N-of-1 Trials In Children With Hypertension
NCT03461003
44932.7%
Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
NCT00874432
24365.1%
Curing Atrial Fibrillation in Heart Failure
NCT00292162
โ€”4122%
Cardiovascular Prevention for Persons With HIV
NCT00982189
โ€”372.7%
The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count
NCT01409837
2330%
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
NCT02412761
โ€”3237.5%
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
NCT01535235
4310%
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
NCT01691781
โ€”2740.7%
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
NCT00459056
32552%
Cardiomyopathy in DMD: Lisinopril vs. Losartan
NCT01982695
โ€”230%
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
NCT01491919
12231.8%
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
NCT01880528
22138.1%
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
NCT00814255
22157.1%
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
NCT01658657
โ€”1741.2%